Announced Tue, 25 Aug, 2026 · 21:02 IST
Honasa Consumer calls off Fluence Pharma acquisition
HONASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹485.00
prior close
₹486.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.1-0.4-0.6+0.1-3.1+0.0-2.2-3.1-3.1-5.3-3.7——
Up moveDown movePending
AI summary
Honasa Consumer has called off its proposed acquisition of 58 percent equity stake in Fluence Pharma Pvt Ltd due to non-fulfilment of closing conditions under the Share Purchase Agreement. The deal, announced on June 23, 2026, has been terminated. The company remains committed to its Nutraceutical strategy and will evaluate other organic and inorganic opportunities.
Likely market impact
Deal cancellation removes expected inorganic boost to Nutraceutical segment. Company will seek other opportunities, but near-term growth plans may slow.